8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

July 20, 2012

Date of Report (Date of earliest event reported)

MOLEX INCORPORATED

(Exact name of registrant as specified in its charter)

Delaware	0-7491	36-2369491
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

2222 Wellington Court, Lisle, Illinois 60532

(Address and zip code of principal executive offices)

(630) 969-4550

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On July 20, 2012, Martin P. Stark, Vice Chairman and Chief Executive Officer of Molex Incorporated issued a statement to employees. A copy of the statement is being furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1        Statement issued by Martin P. Stark to employees of Molex Incorporated dated July 20, 2012

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MOLEX INCORPORATED
Date: July 20, 2012	By:	/s/  Mark R. Pacioni
		Mark R. Pacioni
		Secretary

3

EXHIBIT INDEX

Exhibit No.	Description
Exhibit 99.1	Statement issued by Martin P. Stark to employees of Molex Incorporated dated July 20, 2012

4

EX-99.1

Exhibit 99.1

Memorandum

To: Molex Employees, Family and Friends

From: Martin P. Slark

Date: July 20th, 2012

I deeply regret having to tell you that Fred Krehbiel, our Co-Chairman of the Board, was recently diagnosed with lung cancer.

Because of his role within the Company, we plan to issue a public announcement and we wanted you, as a member of the Molex family, to hear this sad news from me personally. Fred will begin treatment soon and he expects to continue working.

I know you all join me in wishing Fred and his family all the best. He knows your thoughts, prayers and best wishes are with him and has asked me to thank you for your support.

Regards,

Martin

MPS:mk